Search

Turkson-Ocran, Ruth-Alma N, Oluwabunmi Ogungbe, Marian Botchway, Diana Lyn Baptiste, Brenda Owusu, Tiwaloluwa Ajibewa, Yuling Chen, et al. 2024. “Hypertension Management to Reduce Racial/Ethnic Disparities: Clinical and Community-Based Interventions.”. Current Cardiovascular Risk Reports 18 (12): 239-58.

Dibble, Christian C, Samuel A Barritt, Grace E Perry, Evan C Lien, Renee C Geck, Sarah E DuBois-Coyne, David Bartee, et al. 2022. “PI3K Drives the de Novo Synthesis of Coenzyme A from Vitamin B5.”. Nature 608 (7921): 192-98.

Kishikawa, Takahiro, Hiroshi Higuchi, Limei Wang, Nivedita Panch, Valerie Maymi, Sachem Best, Samuel Lee, et al. 2021. “WWP1 Inactivation Enhances Efficacy of PI3K Inhibitors While Suppressing Their Toxicities in Breast Cancer Models.”. The Journal of Clinical Investigation 131 (24).

Morel, Katherine L, Anis A Hamid, John G Clohessy, Nicole Pandell, Leigh Ellis, and Christopher J Sweeney. 2021. “NF-κB Blockade With Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants.”. Molecular Cancer Research : MCR 19 (7): 1137-45.

Chin, Tan-Min, Gandhi T K Boopathy, Ellen P S Man, John G Clohessy, Eva Csizmadia, Margaret P Quinlan, Thomas Putti, et al. 2020. “Targeting Microtubules Sensitizes Drug Resistant Lung Cancer Cells to Lysosomal Pathway Inhibitors.”. Theranostics 10 (6): 2727-43.

Lee, Yu-Ru, Ming Chen, Jonathan D Lee, Jinfang Zhang, Shu-Yu Lin, Tian-Min Fu, Hao Chen, et al. 2019. “Reactivation of PTEN Tumor Suppressor for Cancer Treatment through Inhibition of a MYC-WWP1 Inhibitory Pathway.”. Science (New York, N.Y.) 364 (6441).

Clohessy, John G, and Pier Paolo Pandolfi. 2018. “The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care.”. Frontiers in Oncology 8: 340.

Chew, Chen Li, Andrea Lunardi, Federico Gulluni, Daniel T Ruan, Ming Chen, Leonardo Salmena, Michiya Nishino, et al. 2015. “In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.”. Cancer Discovery 5 (7): 740-51.

Gonzalez-Billalabeitia, Enrique, Nina Seitzer, Su Jung Song, Min Sup Song, Akash Patnaik, Xue-Song Liu, Mirjam T Epping, et al. 2014. “Vulnerabilities of PTEN-TP53-Deficient Prostate Cancers to Compound PARP-PI3K Inhibition.”. Cancer Discovery 4 (8): 896-904.

Sadow, Peter M, Carmen Priolo, Simona Nanni, Florian A Karreth, Mark Duquette, Roberta Martinelli, Amjad Husain, et al. 2014. “Role of BRAFV600E in the First Preclinical Model of Multifocal Infiltrating Myopericytoma Development and Microenvironment.”. Journal of the National Cancer Institute 106 (8).